228 related articles for article (PubMed ID: 9097304)
21. [Cycloplegic effectiveness of cyclopentolate and tropicamide preparations compared with atropinization].
Proskurina OV
Vestn Oftalmol; 2002; 118(6):42-5. PubMed ID: 12506660
[TBL] [Abstract][Full Text] [Related]
22. Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye.
Stadtbäumer K; Frommlet F; Nell B
Vet Ophthalmol; 2006; 9(4):233-7. PubMed ID: 16771758
[TBL] [Abstract][Full Text] [Related]
23. Atropine versus cyclopentolate plus tropicamide in esodeviations.
Goldstein JH; Schneekloth BB
Ophthalmic Surg Lasers; 1996 Dec; 27(12):1030-4. PubMed ID: 8976523
[TBL] [Abstract][Full Text] [Related]
24. Cycloplegic refractions in children who never wore and who always wore prescribed spectacles for refractive accommodative esotropia: exploring the natural history of this form of strabismus and the effect of treatment on their hyperopia.
Khan AO
Binocul Vis Strabismus Q; 2009; 24(3):151-6. PubMed ID: 19807687
[TBL] [Abstract][Full Text] [Related]
25. A randomized clinical trial using atropine, cyclopentolate, and tropicamide to compare refractive outcome in hypermetropic children with a dark iris; skin pigmentation and crying as significant factors for hypermetropic outcome.
van Minderhout HM; Joosse MV; Grootendorst DC; Schalij-Delfos NE
Strabismus; 2019 Sep; 27(3):127-138. PubMed ID: 31234691
[No Abstract] [Full Text] [Related]
26. Response: Cycloplegia in refraction: age and cycloplegics.
Sanfilippo PG; Chu BS; Bigault O; Kearns LS; Boon MY; Young TL; Hammond CJ; Hewitt AW; Mackey DA
Acta Ophthalmol; 2016 Aug; 94(5):e373. PubMed ID: 27167468
[No Abstract] [Full Text] [Related]
27. The difference between cycloplegic and non-cycloplegic autorefraction and its association with progression of refractive error in Beijing urban children.
Lin Z; Vasudevan B; Ciuffreda KJ; Zhou HJ; Mao GY; Wang NL; Liang YB
Ophthalmic Physiol Opt; 2017 Jul; 37(4):489-497. PubMed ID: 28503812
[TBL] [Abstract][Full Text] [Related]
28. A cross-over study of the cycloplegic effects of a single topical application of cyclopentolate-phenylephrine and routine atropinization for 3.5 days.
Zetterström C
Acta Ophthalmol (Copenh); 1985 Oct; 63(5):525-9. PubMed ID: 3907259
[TBL] [Abstract][Full Text] [Related]
29. Optimal dosage of cyclopentolate 1% for complete cycloplegia: a randomized clinical trial.
Bagheri A; Givrad S; Yazdani S; Reza Mohebbi M
Eur J Ophthalmol; 2007; 17(3):294-300. PubMed ID: 17534806
[TBL] [Abstract][Full Text] [Related]
30. Changes of higher-order aberrations with the use of various mydriatics.
Kim JH; Lim T; Kim MJ; Tchah H
Ophthalmic Physiol Opt; 2009 Nov; 29(6):602-5. PubMed ID: 19663926
[TBL] [Abstract][Full Text] [Related]
31. Relationship between cycloplegic and wavefront-derived refraction.
Fernández de Castro LE; Sandoval HP; Al Sarraf O; Vroman DT; Solomon KD
J Refract Surg; 2003; 19(6):S677-81. PubMed ID: 14640434
[TBL] [Abstract][Full Text] [Related]
32. [Cycloplegia with cyclopentolate for testing-refraction of children (author's transl)].
Stangler-Zuschrott E
Klin Monbl Augenheilkd; 1979 Jul; 175(1):95-9. PubMed ID: 582836
[TBL] [Abstract][Full Text] [Related]
33. Visual acuity after cycloplegia in children: implications for atropine penalization.
Wallace DK
J AAPOS; 1999 Aug; 3(4):241-4. PubMed ID: 10477227
[TBL] [Abstract][Full Text] [Related]
34. Tropicamide Versus Cyclopentolate for Cycloplegic Refraction in Pediatric Patients With Brown Irides: A Randomized Clinical Trial.
Al-Thawabieh W; Al-Omari R; Abu-Hassan DW; Abuawwad MT; Al-Awadhi A; Abu Serhan H
Am J Ophthalmol; 2024 Jan; 257():218-226. PubMed ID: 37797867
[TBL] [Abstract][Full Text] [Related]
35. Acute psychotic reaction caused by topical cyclopentolate use for cycloplegic refraction before refractive surgery: case report and review of the literature.
Mirshahi A; Kohnen T
J Cataract Refract Surg; 2003 May; 29(5):1026-30. PubMed ID: 12781295
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of a Cycloplegic Agent Administered as a Spray in the Pediatric Population.
Vagge A; Del Noce C; Pellegrini M; Cappelli F; Musolino M; Bernabei F; Giannaccare G; Traverso CE
J Pediatr Ophthalmol Strabismus; 2020 Sep; 57(5):301-304. PubMed ID: 32956479
[TBL] [Abstract][Full Text] [Related]
37. Comparison of objective refraction in darkness to cycloplegic refraction: a pilot study.
Vasudevan B; Ciuffreda KJ; Meehan K; Grk D; Cox M
Clin Exp Optom; 2016 Mar; 99(2):168-72. PubMed ID: 26888570
[TBL] [Abstract][Full Text] [Related]
38. A Clinical Randomized Trial Comparing the Cycloplegic Effect of Cyclopentolate Drops Applied to Closed Eyelids Versus Open Eyelids.
Zurevinsky J; Sawchuk K; Lim HJ; Lee CH; Rubab S
Am Orthopt J; 2016 Jan; 66(1):114-121. PubMed ID: 27799585
[TBL] [Abstract][Full Text] [Related]
39. CLINICAL EVALUATION OF A NEW MYDRIATIC-MYDRILATE.
Cowan EC; Archer D
Br J Ophthalmol; 1962 Dec; 46(12):730-6. PubMed ID: 18170843
[No Abstract] [Full Text] [Related]
40. [Research of cyclopentolate 1% on the effect of cycloplegia for Chinese hyperopic children].
Wang XM; Ma LX; Wang LH
Zhonghua Yan Ke Za Zhi; 2011 Nov; 47(11):989-94. PubMed ID: 22336064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
